Title: Senior Director of Hematology, Oncology, and Global Project Management
Company: Thermo Fisher Scientific, Inc.
Location: Spring, Texas, United States
Veronica Vlad, senior director of hematology, oncology, and global project management at Thermo Fisher Scientific, Inc., formerly Clinical Research Group, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in health care and oncology.
With over two decades of experience to her credit, Dr. Vlad has excelled as a leader in the field of oncology research. Prior to her current role as senior director of hematology, oncology, and global project management at Thermo Fisher Scientific, Inc., she held key positions at IQVIA Inc., formerly Quintiles Inc. USA, and Theradex, contributing significantly to the advancement of clinical trials and drug development. She began her career as a clinical research associate at GSK plc, laying the foundation for her distinguished trajectory in the medical field.
Before embarking on her professional path, Dr. Vlad pursued an education at “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania, where she earned her Doctor of Medical Sciences in 1997. She continued her academic efforts, specializing in oncology research and clinical project management. In light of her impressive undertakings, she has accrued several accolades throughout her career, including the “Work Worth Doing” Special Performance Award and “The GSK European Award for the Best GSK Employee.” Recognized for her exceptional contributions to oncology research, she has been a driving force in shaping the future of the industry.
Beyond her responsibilities within the field, Dr. Vlad has participated in numerous endeavors outside of her professional circles, contributing her expertise to organizations such as Texas Children’s Hospital and St. Jude Children’s Research Hospital. She has also been actively involved in professional associations like the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA). Looking toward the future, she remains dedicated to her mission of advancing cancer care and improving patient outcomes. With her fluency in multiple languages and her passion for research, she continues to inspire and mentor aspiring professionals, leaving an indelible mark on the field of oncology.
For more information, please visit:
Contact Dr. Vlad:
